A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...
It’s become a bit of a tradition for me to recap the Nobel Prizes in my column: In 2023, I covered Claudia Goldin’s work in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback